Aperam (APEMY) Short Interest Ratio & Short Volume → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free APEMY Stock Alerts $28.58 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort Interest Aperam Short Interest DataCurrent Short Volume1,600 sharesPrevious Short Volume1,600 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$46,784.00Short Interest Ratio / Days to Cover8.0Last Record DateApril 30, 2024Outstanding Shares78,040,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume10 sharesAverage Trading Volume414 sharesToday's Volume Vs. Average2% Short Selling Aperam ? Sign up to receive the latest short interest report for Aperam and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAPEMY Short Interest Over TimeAPEMY Days to Cover Over TimeAPEMY Percentage of Float Shorted Over Time Ad Crypto 101 MediaA ‘DeFi Summer’ Projected!Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. Aperam Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,600 shares $46,784.00 No ChangeN/A8 $29.24 4/15/20241,600 shares $49,328.00 No ChangeN/A3.2 $30.83 3/31/20241,600 shares $50,144.00 -5.9%N/A2.7 $31.34 3/15/20241,700 shares $51,153.00 +6.3%N/A8.5 $30.09 2/29/20241,600 shares $52,800.00 No ChangeN/A16 $33.00 2/15/20241,600 shares $53,655.84 No ChangeN/A0.9 $33.53 Get the Latest News and Ratings for APEMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aperam and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,600 shares $50,256.00 No ChangeN/A8 $31.41 12/31/20231,600 shares $57,696.00 No ChangeN/A1.2 $36.06 12/15/20231,600 shares $54,328.00 No ChangeN/A8 $33.96 11/30/20231,600 shares $53,296.00 No ChangeN/A5.3 $33.31 11/15/20231,600 shares $45,728.00 -5.9%N/A4 $28.58 10/31/20231,700 shares $46,454.20 -22.7%N/A5.7 $27.33 10/15/20232,200 shares $64,713.00 +4.8%N/A7.3 $29.42 9/30/20232,100 shares $60,177.60 +5.0%N/A4.2 $28.66 9/15/20232,000 shares $58,000.00 +11.1%N/A5 $29.00 8/31/20231,800 shares $51,300.00 -25.0%N/A1.5 $28.50 8/15/20232,400 shares $71,532.00 -7.7%N/A6 $29.81 7/31/20232,600 shares $80,886.00 +13.0%N/A2 $31.11 7/15/20232,300 shares $74,819.00 +9.5%N/A5.8 $32.53 6/30/20232,100 shares $65,289.00 -4.6%N/A2.1 $31.09 6/15/20232,200 shares $78,691.36 No ChangeN/A3.1 $35.77 5/31/20232,200 shares $75,636.00 No ChangeN/A2.2 $34.38 5/15/20232,200 shares $79,508.00 No ChangeN/A7.3 $36.14 4/30/20232,200 shares $76,406.00 -8.3%N/A3.7 $34.73 4/15/20232,400 shares $87,252.00 -4.0%N/A4 $36.36 3/31/20232,500 shares $90,675.00 -10.7%N/A5 $36.27 3/15/20232,800 shares $98,252.00 +47.4%N/A1.1 $35.09 2/28/20231,900 shares $74,660.50 -5.0%N/A1.3 $39.30 2/15/20232,000 shares $75,980.00 -4.8%N/A1.3 $37.99 1/31/20232,100 shares $82,618.20 -16.0%N/A1.2 $39.34 1/15/20232,500 shares $94,287.50 -10.7%N/A1 $37.72 12/30/20222,800 shares $88,648.00 +21.7%N/A1.4 $31.66 12/15/20222,300 shares $70,863.00 +21.1%N/A3.8 $30.81 11/30/20221,900 shares $58,624.50 -29.6%N/A2.7 $30.86 11/15/20222,700 shares $79,461.00 No ChangeN/A6.8 $29.43 10/31/20222,700 shares $70,605.00 +22.7%N/A5.4 $26.15 10/15/20222,200 shares $56,848.00 +4.8%N/A5.5 $25.84 9/30/20222,100 shares $51,933.00 +10.5%N/A10.5 $24.73 9/15/20221,900 shares $51,300.00 +18.8%N/A3.8 $27.00 8/31/20221,600 shares $43,576.00 No ChangeN/A3.2 $27.24The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)Nanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development APEMY Short Interest - Frequently Asked Questions What is Aperam's current short interest? Short interest is the volume of Aperam shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,600 shares of APEMY short. Learn More on Aperam's current short interest. What is a good short interest ratio for Aperam? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APEMY shares currently have a short interest ratio of 8.0. Learn More on Aperam's short interest ratio. How does Aperam's short interest compare to its competitors? Here is how the short interest of companies in the sector of "basic materials" compare to Aperam: Algoma Steel Group Inc. (3.28%), Grupo Simec, S.A.B. de C.V. (0.00%), Carpenter Technology Co. (3.27%), Commercial Metals (2.27%), Ternium S.A. (0.21%), United States Steel Co. (8.62%), Materion Co. (1.52%), Ero Copper Corp. (1.77%), Equinox Gold Corp. (3.52%), First Majestic Silver Corp. (6.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Aperam stock? Short selling APEMY is an investing strategy that aims to generate trading profit from Aperam as its price is falling. APEMY shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aperam? A short squeeze for Aperam occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APEMY, which in turn drives the price of the stock up even further. How often is Aperam's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APEMY, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ASTL Short Squeeze SIM Short Squeeze CRS Short Squeeze CMC Short Squeeze TX Short Squeeze X Short Squeeze MTRN Short Squeeze ERO Short Squeeze EQX Short Squeeze AG Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:APEMY) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceUrgent Nvidia WarningAltimetry